Markets:

Overview

News

Currencies

International

Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

4.190 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Is AMD Stock the Next Big AI Play? ↗

August 02, 2023

Advanced Micro Devices (AMD) stock is in the news Wednesday as investors wonder if the tech company can succeed in the AI market!

Via InvestorPlace

MTCH Stock Price Prediction: Can Match Group Rally 30% From Here? ↗

August 02, 2023

Match Group (MTCH) stock is on the move Wednesday after getting a new price prediction and rating from BTIG analyst Jake Fuller.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 02, 2023

Via Benzinga

Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today? ↗

August 02, 2023

Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering.

Via InvestorPlace

Why Rover Group Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

August 02, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares surged 52.1% to $0.1049 in pre-market trading.

Via Benzinga

Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update

May 11, 2023

Via ACCESSWIRE

Overview Of Value Stocks In The Healthcare Sector ↗

May 01, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 02, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!

Via InvestorPlace

Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering

August 01, 2023

Via ACCESSWIRE

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes ↗

July 30, 2023

Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

July 24, 2023

Via Benzinga

Aptevo Therapeutics Reports 2022 Financial Results and Provides Business Update

March 30, 2023

Via ACCESSWIRE

Aptevo Therapeutics Raises $9.6 Million in Non-Dilutive Funding

March 30, 2023

Via ACCESSWIRE

Overview Of Value Stocks In The Healthcare Sector ↗

February 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 20, 2023

Via Benzinga

Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 19, 2023

Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 19, 2023

Via Benzinga

Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial

February 13, 2023

Via ACCESSWIRE

Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid Tumors

January 09, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 18, 2023

Via Benzinga

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 18, 2023

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Via Benzinga

Aptevo Therapeutics Stock Is Sinking Today - Here's Why ↗

July 18, 2023

Aptevo Therapeutics Inc (NASDAQ: APVO) announced that its bispecific acute myelogenous leukemia (AML) drug candidate APVO436, in combination with venetoclax and azacitidine, achieved positive duration...

Via Benzinga

Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML

July 18, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 04, 2023

Via Benzinga

The Top 7 Growth Stocks in Biotech ↗

March 03, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 31, 2023

Investors can get ready for another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

December 14, 2022

On Wednesday, 115 stocks hit new 52-week lows.

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 13, 2022

Via Benzinga

Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket ↗

December 13, 2022

Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.